previous compound ID: 1500 next compound
InChIKey: NNYBQONXHNTVIJ-UHFFFAOYSA-N
SMILES: CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "JW Hanrahan" "DY Thomas" "B Kus" "R Robert" "E Matthes" "GW Carlile" "D Rotin" "SD Macknight" "J Goepp"

chemical graph of compound 1500





CID is 3308
synonyms found at PubChem are:
etodolac, 41340-25-4, Etodolic acid, Lodine, Ultradol, Lodine XL, Etodolaco, Etodolacum, Ramodar, AY 24236, Etodolacum [INN-Latin], Etodolaco [INN-Spanish], AY-24236, AY-24,236, Edolan, Hypen, CCRIS 3923, 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid, CHEMBL622, NSC 282126, 1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid, 1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid, 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid, Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, MLS000028474, CHEBI:4909, RAK-591, NNYBQONXHNTVIJ-UHFFFAOYSA-N, 2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid, (1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid, 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid, Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, NSC282126, SMR000058443, DSSTox_CID_615, (1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid, (+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid, DSSTox_RID_75691, DSSTox_GSID_20615, Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-, Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-(+-)-, SR-01000000100, etodine, Etodolac [USAN:BAN:INN], Etodolac [USAN:INN:BAN], Etodolsaure, Osteluc, Tedolan, Zedolac, etodolac o, rac-Etodolac, Etodlic Acid, [1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid, Etodolac(Lodine), Lodine SR, KS-1056, Etodolac [USAN:USP:INN:BAN], NCGC00016849-01, Etodolac,(S), Prestwick_209, Etodolacetodolic acid, CAS-41340-25-4, Lodine (TN), Spectrum_001244, Opera_ID_1774, Prestwick0_000231, Prestwick1_000231, Prestwick2_000231, Prestwick3_000231, Spectrum2_001387, Spectrum3_001429, Spectrum4_000410, Spectrum5_001347, D0N1WU, AC1L1FN2, SCHEMBL3903, Lopac0_000479, BSPBio_000301, BSPBio_003138, KBioGR_000680, KBioSS_001724, MLS001077315, MLS006011566, DivK1c_000147, SPECTRUM1501005, Etodolac (JP17/USP/INN), SPBio_001374, SPBio_002222, BPBio1_000333, GTPL7185, DTXSID9020615, CTK4I4719, HMS500H09, KBio1_000147, KBio2_001724, KBio2_004292, KBio2_006860, KBio3_002358, MolPort-001-759-084, NINDS_000147, HMS1568P03, HMS1921B09, HMS2092O20, HMS2095P03, HMS2231D04, HMS3259P10, HMS3261O20, HMS3374G09, HMS3712P03, Pharmakon1600-01501005, BCP28411, Tox21_110644, Tox21_202218, Tox21_500479, ANW-42024, BDBM50016799, CCG-39005, CE0096, MFCD00133313, NSC757821, AKOS015838610, Tox21_110644_1, AC-4231, CS-0832, DB00749, LP00479, LS-7393, NC00718, NSC-282126, NSC-757821, RTR-036749, IDI1_000147, KS-0000000W, NCGC00015399-03, NCGC00015399-04, NCGC00015399-05, NCGC00015399-06, NCGC00015399-07, NCGC00015399-08, NCGC00015399-09, NCGC00015399-11, NCGC00015399-12, NCGC00015399-13, NCGC00015399-15, NCGC00015399-16, NCGC00089769-02, NCGC00089769-03, NCGC00089769-04, NCGC00089769-05, NCGC00089769-06, NCGC00089769-07, NCGC00259767-01, NCGC00261164-01, AN-12214, BC651843, CPD000058443, HY-76251, SAM002589968, SBI-0050463.P003, 110781-63-0 (mono-hydrochloride salt), AB0012214, TR-036749, AB00052194, E0858, EU-0100479, FT-0607046, C06991, D00315, E 0516, K-8734, Pyrano[3, 1,8-diethyl-1,3,4,9-tetrahydro-, AB00052194_17, 340E254, Q-201099, SR-01000000100-2, SR-01000000100-4, SR-01000000100-7, BRD-A74667430-001-05-3, BRD-A74667430-001-15-2, 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid, Etodolac, European Pharmacopoeia (EP) Reference Standard, F2173-0681, Z1820178466, Etodolac, United States Pharmacopeia (USP) Reference Standard, 1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid, 1,8-Diethyl-1,3,4,9-tetrahydropyranol[3,4-b]indole-1-acetic acid, (RS)-2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid, Pyrano(3,4,b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-, Etodolac for peak identification, European Pharmacopoeia (EP) Reference Standard